Literature DB >> 16037245

Analysis of protein glycation products by MALDI-TOF/MS.

Thomas Kislinger1, Andreas Humeny, Carlo C Peich, Cord-Michael Becker, Monika Pischetsrieder.   

Abstract

Matrix-assisted laser desorption ionization-mass spectrometry with time-of-flight detection (MALDI-TOF/MS) is a promising tool to analyze advanced glycation end product (AGE)-modified proteins. The combination of soft ionization (MALDI) with time-of-flight mass detection allows analysis of peptides and proteins of a molecular mass up to 300 kDa with minimal sample workup. Because the direct structural analysis of intact AGE proteins is not possible due to the formation of broad and poorly resolved peaks, peptide mapping was introduced into the analysis of AGE proteins by MALDI-TOF/MS, allowing site-specific analysis of defined AGEs. When methylglyoxal-modified lysozyme was subjected to MALDI-TOF/MS peptide mapping, methylimidazolone and argpyrimidine attached to the arginine residue and carboxyethyl (CEL) bound to the lysine were detected on peptide(aa1-7) (KVFGRCE). In contrast, only one methylimidazolone was found on peptide(aa8-35) (LAAAMKRHGLDNYRGYSLGNWVCAAKFE) and peptide(aa120-129) (VQAWIRGCRL), respectively. The analysis of AGE protein, which had been incubated with glucose, revealed the presence of an Amadori product and a carboxymethyl residue (CML) on peptide(aa1-7) and peptide(aa8-35), as well as an imidazolone A on peptide(aa120-129). Furthermore, the early Maillard reaction of lysozyme, which had been glycated by seven different sugars, was monitored by MALDI-TOF/MS peptide mapping. Finally, this approach was successfully applied for site- and product-specific relative quantification of AGEs. For example, kinetics of CML and Amadori product formation on peptide(aa1-7), as well as imidazolone A formation on peptide(aa120-129), were determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037245     DOI: 10.1196/annals.1333.030

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

Review 1.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

Review 2.  Glycation of antibodies: Modification, methods and potential effects on biological functions.

Authors:  Bingchuan Wei; Kelsey Berning; Cynthia Quan; Yonghua Taylor Zhang
Journal:  MAbs       Date:  2017-03-08       Impact factor: 5.857

Review 3.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

4.  Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Andrew Soulby; Isolda Romero Canelon; Mark Barrow; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-10-15       Impact factor: 3.109

5.  In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry.

Authors:  Leslie Frost; Muhammad Chaudhry; Tiffany Bell; Menashi Cohenford
Journal:  Anal Biochem       Date:  2010-11-26       Impact factor: 3.365

6.  Identification and characterization of glycation adducts on osteocalcin.

Authors:  Corinne J Thomas; Timothy P Cleland; Sheng Zhang; Caren M Gundberg; Deepak Vashishth
Journal:  Anal Biochem       Date:  2017-02-24       Impact factor: 3.365

7.  Measurement of Lens Autofluorescence for Diabetes Screening.

Authors:  Alin Stirban
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

8.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Chunling Wa; Ronald L Cerny; William A Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2007-06-23       Impact factor: 3.786

9.  Study of an unusual advanced glycation end-product (AGE) derived from glyoxal using mass spectrometry.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Isolda Romero Canelon; Mark P Barrow; David Kilgour; Naila Rabbani; Paul J Thornalley; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-28       Impact factor: 3.109

Review 10.  Future technology insight: mass spectrometry imaging as a tool in drug research and development.

Authors:  D F Cobice; R J A Goodwin; P E Andren; A Nilsson; C L Mackay; R Andrew
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.